It is possible that anti-obesity effects of GBR, which might account, at least partially resulted from suppressing dietary fat digestion via inhibition of pancreatic lipase activity with subsequent excretion of the undigested fat, which was consistent with the findings of the in vitro experiment [45]. The gene discussed is PNLIP; the disease is obesity disorder.